Jan 11, 2021 / 04:40PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
All right. Sorry if there was a bit of delay there. I'm Robbie Marcus, the med tech analyst at JPMorgan. Very happy to have the next session, which is DexCom. Have Kevin Sayer, the CEO; and Quentin Blackford, the CFO.
Just a few quick housekeeping items before we jump into the presentation. You can follow along with slides that you can get from the JPMorgan Healthcare website. Feel free on that website to also submit a question. It goes directly to me and no one else and I can ask it for you, or feel free to chat me on Bloomberg or send me an e-mail and I'm happy to try and ask as many questions during the Q&A session.
So with that, Kevin, I'm going to turn it over to you, and I'll join you afterwards for question and answer.
Kevin R. Sayer - DexCom, Inc. - Executive Chairman, CEO & President
Thank you, Robbie. And as you can see, we have our safe harbor slide. So let's get right into talking about a recap of 2020 on Slide #3, for those of you following along.
DexCom Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers